Humanigen to Current at Roth Convention | Business enterprise & Finance
BURLINGAME, Calif.–(Company WIRE)–Mar 5, 2021– Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a scientific stage biopharmaceutical firm
BURLINGAME, Calif.–(Company WIRE)–Mar 5, 2021– Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a scientific stage biopharmaceutical firm